title: BLT2 is a pro-tumorigenic mediator during cancer progression and a therapeutic target for anti-cancer drug development.
abstract: Cancer is a leading cause of death worldwide and has been linked to inflammation. Leukotriene B4 (LTB4) is synthesized from arachidonic acid via the 5-lipoxygenase pathway and is a potent chemoattractant for inflammatory cells. LTB4 was recently shown to be associated with the pathogenesis of inflammatory diseases, including cancer. Of the two known LTB4 receptors, BLT1 and BLT2, the biological roles of the low-affinity LTB4 receptor 2, BLT2, have only recently been elucidated. This review focuses on recent discoveries regarding BLT2 and its roles in cancer progression and the downstream signaling mechanisms of the BLT2-linked signaling cascade in cancer cells. We believe that these findings will facilitate the development of new cancer treatments.
authors: College of Life Sciences and Biotechnology, Korea University Seoul 136-701, Korea.
authors: Nam-Kyu
authors: NK
authors: Cho
authors: Young-Chul
authors: YC
authors: Joo
authors: Jun Dong
authors: JD
authors: Wei
authors: Jae In
authors: JI
authors: Park
authors: Jae-Hong
authors: JH
authors: Kim
keywords: Leukotriene B4 receptor 2 (BLT2); NADPH oxidase; cancer progression; leukotriene B4; nuclear factor-kB; reactive oxygen species
references: Biochem Biophys Res Commun. 2012 Apr 6;420(2):428-33
references: 22426480
references: Free Radic Biol Med. 2010 Sep 15;49(6):1072-81
references: 20600831
references: Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:575-85
references: 12432944
references: Am J Pathol. 2009 Aug;175(2):489-99
references: 19628766
references: FEBS Lett. 1982 Jul 19;144(1):81-4
references: 6286359
references: N Engl J Med. 2007 Nov 1;357(18):1841-54
references: 17978293
references: Cell. 2011 Mar 4;144(5):646-74
references: 21376230
references: Front Pharmacol. 2013 Mar 22;4:27
references: 23525348
references: Ann N Y Acad Sci. 2009 Aug;1171:59-76
references: 19723038
references: Blood. 2007 Jan 15;109(2):626-31
references: 16985179
references: Endocr Rev. 2004 Apr;25(2):276-308
references: 15082523
references: Genomics. 1996 Oct 15;37(2):187-94
references: 8921391
references: FEBS Lett. 2011 Nov 16;585(22):3501-6
references: 22044535
references: J Clin Oncol. 2005 Feb 10;23(5):1011-27
references: 15585754
references: Allergol Int. 2006 Jun;55(2):91-7
references: 17075244
references: J Exp Med. 2005 Jun 20;201(12):1961-71
references: 15955837
references: Lancet. 2012 Dec 15;380(9859):2095-128
references: 23245604
references: Gastroenterology. 1984 Mar;86(3):453-60
references: 6319219
references: Cell Res. 2010 Jan;20(1):24-33
references: 19997086
references: J Immunol. 2010 Apr 1;184(7):3946-54
references: 20194723
references: Cancer Metastasis Rev. 2006 Dec;25(4):695-705
references: 17160708
references: Nat Rev Cancer. 2009 Nov;9(11):798-809
references: 19851315
references: J Invest Dermatol. 2010 Apr;130(4):1095-106
references: 20090768
references: Br J Cancer. 2009 Jan 13;100(1):134-44
references: 19088723
references: Int J Cancer. 2004 Apr 20;109(4):507-15
references: 14991571
references: Oncogene. 2004 Dec 9;23(57):9259-68
references: 15489890
references: Chest. 2003 Apr;123(4):1240-7
references: 12684317
references: Adv Immunol. 2012;116:51-92
references: 23063073
references: Carcinogenesis. 2010 Apr;31(4):543-51
references: 19748928
references: Trends Mol Med. 2008 Oct;14(10):461-9
references: 18774339
references: J Cell Biochem. 2009 Feb 15;106(3):363-71
references: 19115258
references: Nat Rev Cancer. 2001 Dec;1(3):222-31
references: 11902577
references: Biochim Biophys Acta. 2012 Dec;1823(12):2120-9
references: 23017243
references: Dev Cell. 2012 May 15;22(5):1079-91
references: 22542839
references: Mol Cells. 2011 Jul;32(1):1-5
references: 21424583
references: J Immunol. 2010 Nov 15;185(10):6329-37
references: 20952677
references: Oncogene. 2012 May 3;31(18):2309-22
references: 21909139
references: J Clin Invest. 2001 Jan;107(2):143-51
references: 11160127
references: Nat Immunol. 2003 Oct;4(10):965-73
references: 12949533
references: Cancer Res. 2007 Nov 1;67(21):10389-96
references: 17974982
references: Antioxid Redox Signal. 2008 Aug;10(8):1343-74
references: 18522489
references: Cancer Metastasis Rev. 2006 Sep;25(3):307-13
references: 17029030
references: Br J Cancer. 2008 Oct 7;99(7):1064-73
references: 18781173
references: Oncogene. 2004 Apr 29;23(20):3550-60
references: 15116091
references: Exp Mol Med. 2010 Dec 31;42(12):833-41
references: 20966635
references: Nature. 2008 Jul 24;454(7203):436-44
references: 18650914
references: Clin Cancer Res. 2002 Apr;8(4):945-54
references: 11948098
references: Oncogene. 2010 Feb 25;29(8):1167-78
references: 19935719
references: Semin Cancer Biol. 2004 Apr;14(2):105-14
references: 15018894
references: Biotechnol Adv. 2012 Nov-Dec;30(6):1524-32
references: 22537875
references: J Steroid Biochem Mol Biol. 1999 Apr-Jun;69(1-6):307-13
references: 10419007
references: PLoS One. 2012;7(11):e49186
references: 23145117
references: Nature. 2002 Dec 19-26;420(6917):860-7
references: 12490959
references: Nat Rev Cancer. 2007 Oct;7(10):800-8
references: 17851543
references: Prostaglandins Leukot Essent Fatty Acids. 2003 Aug-Sep;69(2-3):123-34
references: 12895595
references: Biochem Biophys Res Commun. 2000 Aug 2;274(2):377-82
references: 10913346
references: Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):915-20
references: 19286633
references: Nature. 2006 May 25;441(7092):431-6
references: 16724054
references: Immunol Rev. 2012 Mar;246(1):379-400
references: 22435567
references: J Biol Chem. 2012 Apr 20;287(17):13840-9
references: 22396544
references: Clin Cancer Res. 2008 Nov 1;14(21):6735-41
references: 18980965
references: Cardiovasc Res. 2009 Jan 1;81(1):216-25
references: 18852255
references: Clin Cancer Res. 2003 Jul;9(7):2786-97
references: 12855659
references: Arch Biochem Biophys. 2001 Jan 15;385(2):231-41
references: 11368003
references: Nat Rev Cancer. 2010 Mar;10(3):181-93
references: 20168319
references: Exp Mol Med. 2011 Mar 31;43(3):129-37
references: 21252614
references: J Exp Med. 2006 Apr 17;203(4):837-42
references: 16567388
references: Exp Mol Med. 2012 Jun 30;44(6):378-86
references: 22391335
references: Gastroenterology. 2007 Nov;133(5):1637-48
references: 17983808
references: J Exp Med. 2008 Apr 14;205(4):759-66
references: 18378794
references: J Exp Med. 2000 Aug 7;192(3):421-32
references: 10934230
references: Cytokine Growth Factor Rev. 2010 Feb;21(1):11-9
references: 20018552
references: Biochem Pharmacol. 1994 Jan 13;47(1):145-9
references: 8311838
references: Cell. 2010 Mar 19;140(6):883-99
references: 20303878